drugset / Trial / NCT03004495

Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001

NCT03004495

RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate systemic pharmacokinetics of CHF6001 following concomitant administration of CHF6001 and CHF5259, in comparison with the single components, administered in healthy subjects via a multi-dose reservoir NEXThaler® DPI.

Timeline

Start
2016-01
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycopyrrolate Small molecule 25 ug Inhaled
Subject TRANIMILAST Small molecule Inhaled